Trump’s Covid Drug, Genetics and Risks

The anti-malaria drug that is being touted by President Donald Trump as a Covid treatment has associated risks, including a genetic-based risk for people with ethnic ties to tropical regions where malaria is most common. Descendants from those regions can carry a genetic characteristic that is an age-old immunity adaptation that resists malaria. The occurrence…

Thank you for reading!

To continue reading this article you must be registered and logged into this site. If you already have an account please login now, otherwise you can click here to register for new account. Registration is FREE.

Login       Register

The latest Alabama business news delivered to your inbox